In April 2009 the BCBSA Technology Evaluation Center Medical Advisory Panel determined that: "radiofrequency catheter ablation of the pulmonary veins as a treatment for atrial fibrillation meets the ...
NATICK, Mass., The first patient has been treated in the Boston Scientific Corporation ZERO AF clinical trial to evaluate the safety and effectiveness of the Blazer® Open-Irrigated Temperature ...
In patients with medically refractory paroxysmal atrial fibrillation, the safety and efficacy of pulsed field ablation as compared with conventional thermal ablation are unknown. New research findings ...
MARLBOROUGH, Mass., June 16, 2020 /PRNewswire/ -- CardioFocus, Inc. today announced that the first U.S. patients have been treated commercially with the recently-approved HeartLight ® X3 Endoscopic ...
The ThermoCool Atrial Fibrillation (AF) Trial Investigators have demonstrated that patients with paroxysmal AF who undergo catheter ablation have fewer symptomatic recurrences of atrial arrhythmias, ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved a navigation-enabled ablation catheter for the treatment of ...
PFA was noninferior to cryoablation for first recurrence of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation. Tissue-selective energy delivery and short application times offer ...
Using cryoablation as first-line therapy in patients with newly diagnosed, paroxysmal atrial fibrillation can significantly reduce the risk of recurrence measured by continuous arrhythmia monitoring ...
MANY common arrhythmias observed in both atria and ventricles are similar although the atrial types have a few important distinguishing features. Thus, so far as therapy is concerned, the atrial ...
Atrial fibrillation (AFib) is a type of irregular heartbeat. If you have it, your doctor will classify yours by the reason for it and on how long it lasts. When your heartbeat returns to normal within ...
Adults with atrial fibrillation with overweight or obesity were less likely to experience recurrent atrial arrhythmia when ...
It is recommended that RFA as a treatment for paroxysmal atrial fibrillation refractory to drug therapy meets CTAF TA criteria 1–5 for improvement in health outcomes in relatively young patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback